Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OLA1 pseudogene 2 (OLA1P2)
- Target
- OLA1P2
- Molecular classification
- Other (Pseudogene; processed pseudogene; retrocopy of OLA1)
01
Overview
OLA1 pseudogene 2 (OLA1P2) is a processed (retroposed) pseudogene derived from the parental gene OLA1, located on chromosome 4 in humans[7]. Unlike the functional OLA1 gene, which encodes a GTPase/ATPase involved in cell cycle regulation, stress response, and cancer progression, OLA1P2 does not encode a functional protein and is not known to serve as a receptor, enzyme, or transporter. There are currently no validated biological functions, disease associations, drug interactions, or clinical roles for OLA1P2. Its sequence is primarily used for comparative genomics and does not serve as a recognized target for therapeutic intervention[3][5][7][8][13].
- Other names
- OLA1P2Obg-like ATPase 1 pseudogene 2
02
Biological functions
Pseudogenes sometimes participate in gene regulation as non-coding RNAs or as competitive endogenous RNAs (ceRNAs) that can regulate parental gene expression, although no functions specific to OLA1P2 have been established[13][10][8].No established protein or enzymatic functions.
03
Disease associations
Most pseudogenes do not encode active proteins and are not generally implicated as direct drivers in disease.Some pseudogenes have regulatory roles in cancer and other diseases (acting as ceRNAs), but there are no validated disease associations for OLA1P2 so far[12][13][10].
04
Safety considerations
None relevant; as OLA1P2 is not an active target, there are no safety concerns or therapeutic challenges associated with its targeting.
Beyond the preview
Go deeper on OLA1 pseudogene 2 (OLA1P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OLA1 pseudogene 2 (OLA1P2).